4. TUBERCULAR MENINGITIS
Most common form of CNS tuberculosis
If untreated, high frequency of Neurological sequelae and
Mortality
TBM complicates 0.3 %of untreated TB infections in children
Common between 6 months and 4yrs of age
Clinical progression- Rapid or Gradual
Rapid progression more often in infants and young children
Ocassionally , TBM occurs many years after the infection
5. EPIDEMIOLOGY
Comprises 1% of total TB cases
5-10% of extra pulmonary TB cases
TBM comprises 70-80% of CNS tuberculosis
RISK FACTORS
Young age
HIV infection
Malnutrition
Immunosupression
Recent meseals/ pertusis infection
6. PATHOLOGY
primary infection
Lymphohematogenous dissemination
Metastatic caseous lesion in the cerebral cortex or meninges
Discharges few tubercule bacilli into the sub arachnoid space
Forms gelatinous exudate( sylvian fissure, basal cistern)
Infiltrates the cortico meningeal blood vessels
Inflammation, obstruction and infarction of cerebral cortex
brainstem ( commonest site ) interferes CSF flow
CN III, VI and VII dysfunction Hydrocephalus
7. CLINICAL FEATURES # MRC STAGING
First stage( prodromal stage or stage of invasion)
Lasts for 1-2 week ( Non specific symptoms)
Low grade Fever
Loss of appetite
Disturbed sleep
Drowsiness , irritability, photophobia
Malaise
Stagnation or loss of development milestones
Focal neurologic signs are absent
8. SECOND STAGE( MENINGITIS)
Begins more abruptly Some with encephalitis
high grade fever - Disorientation
Nuchal rigidity / hypertonia - Movement disorders
Seizures - Speech impairment
Positive Kernig’s and Brudzinski signs
Cranial nerve palsies / Focal neurological signs
Hydrocephalus / Vasculitis
9.
10. THIRD STAGE(STAGE OF COMA)
Coma
Hemi or paraplegia
Hypertension
Decerebrate posturing
Deterioration of vital signs
Death
11.
12. DIAGNOSIS
TST – Nonreactive in up to 50 % OF cases
CXR 20-50% of children have a normal findings
HIV serology
Lumbar CSF study
Polymerase chain reaction (PCR)
Cultures of other body fluids can help confirm the diagnosis
Neuro imaging
13. CSF STUDY
CSF pressure may reach to 30-40 mmhg
CSF cells – leukocytes 10-500 cells/ microL( Lymphocytes)
CSF glucose - < 2/3rd of blood glucose
CSF protein – markedly high (400 – 5000 mg/dl)
Early stage 1 - viral aseptic meningitis then progress severly
Success of CSF study reated to its volume
5-10 ml of lumbar CSF
Acid –fast stain positive in up to 30 % of cases
Culture is positive in 50-70% of cases
14.
15. A pellicle or coagulum ( cob web pattern) is formed by CSF on
standing in a tube.
CSF ADA levels > 8 IU/L suggestive of TBM
CSF INF-Y assay +
CSF lactate levels 5-10 mmol/litre
16. RADIOGRAPHIC CHANGES
CT or MRI – brain
Normal during early stages of the disease
As disease progresses
- basilar enhancement
- communicating hydrocephalus
- signs of cerebral edema
One or several clinical silent tuberculomas
17.
18. TUBERCULOMA
Another manifestation of CNS tuberculosis
Tumor like mass
Formed by aggregation of caseous tubercles
Singular / multiple
Clinically manifests as a brain tumor
Account for upto 30 % of brain tumors
20. DIAGNOSIS
TST is usually reactive
Chest radiograph is usually normal
CT or MRI – brain
-Discrete lesions with surrounding edema
-Contrast medium enhancement shows ring like lesion
Surgical excision
To distinguish tuberculoma from other causes of brain tumor
21. Treatment
Corticosteroids
- alleviates severe clinical signs and symptoms
- used during 1st few weeks of treatment or
- in immediate post op period to decrease cerebral edema
surgical removal is not necessary
- most tuberculoma subside with medical management( later)
24. PROGNOSIS
Correlates most closely with
- clinical stage of illness at the time treatment is initiated and age of onset
Untreated cases die within 4-8 weeks
Most with 1st stage have an excellent outcome ( RECOVERY IS RULE)
2ND Stage mortality is 25% and 25% of the survivor suffer neurological deficits.
Most with 3rd stage , mortality is 50% and those who survive have permanent disabilities
- blindness
- deafness
- paraplegia
- diabetes insipidus
- mental retardation
Prognosis for young infants is worse than for older children
25. TREATMENT
1. Anti tubercular therapy
2. Corticosteroids
3. Symptomatic therapy
Anti Tubercular therapy
ATT for 12 months
- intensive ( 2 months) + continuation phase ( 10 months)
i.e 2HRZE(S) + 10 HR
Children with TBM should be hospitalized
- preferably for first 2 months / until clinically stabilized
Intensive phase – HRZE/S FOR 2 MONTHS
Continuation phase- HR for 10 months
26. Corticosteroids
Parenteral dexamethasone 0.15 mg every 6 hourly IV,
Then oral prednisolone
HIV negative
- All children with TB meningitis at 2 mg / kg daily for 4 weeks
- Then gradually tapered over 1-2 weeks before stopping
HIV positive
- advised in the absence of the threatening opportunistic infections
ATT to be considered for any child who develops
- basilar meningitis
- hydrocephalus
- CN palsies , stroke with no other apparent etiology
27. SYMPTOMATIC TREATMENT
Treat seizure, raised ICP , dyselectrolytemia.
Observe for papillodema, optic atrophy, hydrocephalus.
Ventriculo caval shunt in case of increasing head circumference
and persistent decerebration.
Often the key to the correct diagnosis
- identifying an adult with TB who is in contact with the child
TBM has short incubation period / rapid progression
- Needs high index of suspicion
28. REFERENCES
Nelson textbook of pediatrics , 21st edition
Ghai textbook of pediatrics 9th edition
National guidelines for extra pulmonary TB
PG textbook of pediatrics by Piyush Gupta